Presbyterian Kaseman Hospital | Oncology Department

Research site

(Unclaimed)

Location

8300 Constitution Avenue Ne, Albuquerque, New Mexico, United States of America

Site insights

Top conditions

Top treatments

Paclitaxel

Cisplatin

Trastuzumab

Atezolizumab

Nivolumab

Bevacizumab

Exemestane

Gemcitabine Hydrochloride

Lenalidomide

Pembrolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 84 total trials

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor D...

Enrolling

Stage III Colon Cancer

Drug: mFOLFOX6 3-6 month

Device: Signatera test

S0820, Adenoma and Second Primary Prevention Trial (PACES)

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and...

Active, not recruiting

Colorectal Neoplasms

Drug: Eflornithine placebo & sulindac placebo

Drug: Eflornithine plus sulindac

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

This is a multicenter, open-label, Phase 1 study of orally administered VMD-928 in adult subjects with advanced solid tumors or lymphoma that have pr...

Enrolling

Breast Cancer

Adenoid Cystic Carcinoma

Drug: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)

T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in pa...

Enrolling

Anatomic Stage III Breast Cancer AJCC V8

Anatomic Stage IIIA Breast Cancer AJCC V8

Biological: Trastuzumab Emtansine

Other: Quality-of-Life Assessment

Locations recently updated

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling

Multiple Myeloma

Advanced Solid Tumors

Drug: Trastuzumab and Pertuzumab

Drug: Palbociclib